Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01958073 · ClinicalTrials.gov registry record · Phase 4
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
A Phase 4 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT01958073 is a Phase 4 study that has completed, run by University of California, San Diego. The registered enrollment target is 35 participants.
The verdict
NCT01958073, a Phase 4 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
The investigators would like to know if the use of vaginally applied estrogen can prevent the problem of repeated urinary tract infections (UTI) in women who have gone through menopause. The investigators will use two forms of vaginal estrogen that are available by prescription (a ring and a cream) and compare their efficacy to that of a placebo (without any active ingredient). The investigators are going to look at if the vaginal estrogen can prevent UTIs altogether and also the number of UTIs each group experiences over a 6 month period. After 6 months, all subjects will receive vaginal estrogen and the women on the non-active treatment will be able to choose whether they would like to use either the estrogen ring or cream. The investigators will then be able to compare the number of UTIs on and off active vaginal estrogen treatment within those subjects who started on the placebo. The investigators are also going to look at quality of life before and during treatment using questionnaires and whether subjects stop using the treatments or do not use them as directed (compliance).
Interventions
- DRUG Placebo
- DRUG Conjugated Estrogen Vaginal Cream
- DRUG Estradiol Ring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2013-10 |
| Est. Completion | 2017-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01958073
The ClinicalTrials.gov registry entry for NCT01958073 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01958073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01958073 about?
NCT01958073 is a clinical study titled "Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women". The investigators would like to know if the use of vaginally applied estrogen can prevent the problem of repeated urinary tract infections (UTI) in women who have gone through menopause. The investigators will use two forms of vaginal estrogen that are available by prescription (a ring and a cream) ...
What is the current status of trial NCT01958073?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2013-10. Estimated completion is 2017-12.
What interventions are being tested in trial NCT01958073?
The interventions under investigation include: Placebo (DRUG), Conjugated Estrogen Vaginal Cream (DRUG), Estradiol Ring (DRUG).
Who is sponsoring clinical trial NCT01958073?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.